Glenmede Trust CO Na Amarin Corp Plcuk Transaction History

Glenmede Trust CO Na

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$4.04 - $5.31 $8,888 - $11,682	-2,200 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$4.78 - $8.26 $6,214 - $10,738	1,300 Added 144.44%	2,200 $15,000
Q4 2019 Feb 12, 2020	SELL	$13.94 - $24.12 $5,576 - $9,648	-400 Reduced 30.77%	900 $19,000
Q3 2019 Nov 14, 2019	BUY	$13.89 - $23.16 $5,556 - $9,264	400 Added 44.44%	1,300 $19,000
Q2 2019 Aug 13, 2019	BUY	$16.27 - $20.51 $14,643 - $18,459	900 New	900 $17,000

176

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $202M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.